
NASDAQHealthcareMedical - Healthcare Information Services
最新数据
US$35.82
+US$0.99 · +2.84%
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
前收盘价
US$35.82
+US$0.99 · +2.84%
盘前
US$36.04
+US$0.22 · +0.61%
10月12日 7:00 ET
盘中时间采用ET。市场数据可能有所延迟。
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
日内区间
当前US$35.82
52周区间
当前US$35.82
盘中时间采用ET。市场数据可能有所延迟。
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
日内区间
当前US$35.82
52周区间
当前US$35.82
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 11.85亿 USD | 11.12亿 USD | 11.47亿 USD | 12.96亿 USD | 11.32亿 USD |
| 销货成本 | 6.77亿 USD | 6.41亿 USD | 6.47亿 USD | 7.07亿 USD | 5.77亿 USD |
| 毛利 | 5.08亿 USD | 4.71亿 USD | 5亿 USD | 5.89亿 USD | 5.55亿 USD |
| 研究与开发 | 8773.5万 USD | 9041.2万 USD | 9328.6万 USD | 1.05亿 USD | 7571.6万 USD |
| 销售、一般及管理费用 | 4.09亿 USD | 3.8亿 USD | 4.26亿 USD | 4.86亿 USD | 3.89亿 USD |
| 营业费用 | 4.96亿 USD | 4.71亿 USD | 5.19亿 USD | 5.91亿 USD | 4.65亿 USD |
| 利息收入 | 1190万 USD | 2490万 USD | 1476万 USD | — | — |
| 利息支出 | 391万 USD | 452.5万 USD | — | 13万 USD | 2238.9万 USD |
| 折旧和摊销 | 8663.4万 USD | 8975.5万 USD | 9555.8万 USD | 9916.9万 USD | 8493.1万 USD |
| 营业利润 | 1166.5万 USD | 33.7万 USD | −1932.9万 USD | −232.3万 USD | 8950.7万 USD |
| 净利润 | 205.2万 USD | 1253.1万 USD | −2037.1万 USD | 564.8万 USD | 7784.9万 USD |
公司数据更新于 2026年10月12日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化,并非 GoAI 建议。
平均目标
US$56.67
上涨空间 58.21%报告持有此股票敞口的交易所交易基金。
iShares Core S&P Small-Cap ETFIJR9485.76万0.09%1031.91亿 USD0.06%US$137.55+0.17%
Vanguard Morningstar Total Stock Market ETFVTI4812.23万0.00%2.3万亿 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM4184.55万0.05%787.4亿 USD0.19%US$278.94+0.49%
Vanguard Morningstar Small-Cap ETFVB3491.74万0.02%1853亿 USD0.03%US$289.48+0.64%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV3038.97万0.11%268.09亿 USD0.33%US$37.95-0.39%
Vanguard Morningstar Small-Cap Value ETFVBR2219.73万0.03%682亿 USD0.05%US$234.43+0.22%
Vanguard Extended Market ETFVXF1861.17万0.02%954亿 USD0.05%US$235+0.80%
Dimensional - US Targeted Value ETFDFAT1707.66万0.06%301.22亿 USD0.33%US$67.27-0.43%
iShares Core S&P Small-Cap ETFIJR
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Morningstar Small-Cap ETFVB
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Morningstar Small-Cap Value ETFVBR
Vanguard Extended Market ETFVXF
Dimensional - US Targeted Value ETFDFATAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。